Month: November 2025

Aprea Therapeutics, Inc. (Nasdaq: APRE) is a clinical-stage biopharmaceutical company pioneering a new era in precision oncology. By combining deep genetic insight with targeted molecular design, Aprea is advancing therapies…

Karbon-X Corp. (OTCQX: KARX) is a vertically integrated climate-solutions company operating across both compliance and voluntary carbon markets. Through its ALLCOT subsidiary and digital carbon-credit trading platform, Karbon-X delivers end-to-end…